Preferential Use of Branched-Chain Amino Acids as an Energy Substrate in Patients with Liver Cirrhosis

Internal Medicine

Volumn 37, Issue 5, 1998, Pages 429-434

  Kato, Masahiko ^a   Miwa, Yoshiyuki ^a   Tajika, Masahiro ^a   Hiraoka, Tetsuya ^a   Muto, Yasutoshi ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Energy efficacy; Indirect calorimetry; Protein energy malnutrition

Indexed keywords

BRANCHED CHAIN AMINO ACID; CREATININE; FATTY ACID; GLUCOSE; NITROGEN; UREA;

ARTICLE; CALORIMETRY; COMPARATIVE STUDY; ENERGY METABOLISM; FEMALE; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; UREA NITROGEN BLOOD LEVEL; URINE;

AMINO ACIDS, BRANCHED-CHAIN; BLOOD UREA NITROGEN; CALORIMETRY, INDIRECT; CREATININE; ENERGY METABOLISM; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NITROGEN; SEVERITY OF ILLNESS INDEX; UREA;

EID: 0032058977     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.429     Document Type: Article

References (43)

1. Morgan AG, Kelleher J, Walker BE, Losowsky MS. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 17: 113, 1976.
2. Freund H, Yoshimura N, Lunetta L, Fischer JE. The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery 83: 611, 1978.
3. Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 2: 420, 1982.
4. Swart GR, van den Berg JWO, van Vuure JK, Rietveld T, Wattimena DL, Freukel M. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 8: 329, 1989.
5. Chalasani N, Gitlin N. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am J Gastroenterol 91: 1266, 1996.
6. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 24: 692, 1989.
7. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 2: 1051, 1967.
8. Zieve Z. The mechanism of hepatic coma. Hepatology 1: 360, 1981.
9. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80: 77, 1976.
10. Miwa Y, Kato M, Moriwaki H, et al. Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure. Hepatology 22: 291, 1995.
11. Lunderquist A, Simert G, Tylén U, Vang J. Follow-up of patients with portal hypertension and esophageal varices treated with percutaneous obliteration of gastric coronary vein. Diagn Radiology 122: 59, 1977.
12. Konstantinides FN, Boehm KA, Radmer WJ, et al. Pyrochemiluminescence: Real time, cost-effective method for determining total urinary nitrogen in clinical nitrogen-balance studies. Clin Chem 34: 2518, 1988.
13. Takala J, Merilainen P. Handbook of Gas Exchange and Indirect Calorimetry. Datex Division Instrumentarium Corp., Helsinki, 1987.
14. Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Carnegie Institute of Washington, Washington DC, 1919; no. 297.
15. Agarwal NR, Savino JA, Feldman M, Dawson J, Gupte P, Del Guercio LR. The automated metabolic profile. Crit Care Med 11: 546, 1983.
16. Owen OE, Trapp VE, Reichard GA Jr, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 72: 1821, 1983.
17. Jhangiani SS, Agarwal N, Holmes R, Cayten CG, Pitchumoni CS. Energy expenditure in chronic alcoholics with and without liver disease. Am J Clin Nutr 44: 323, 1986.
18. Shanbhogue RL, Bistrian BR, Jenkins RL, Jones C, Benotti P, Blackburn GL. Resting energy expenditure in patients with end-stage liver disease and in normal populations. JPEN J Parenteral Enteral Nutr 11: 305, 1987 (see comments).
19. Müller MJ, Fenk A, Lautz HU, et al. Energy expenditure and substrate metabolism in ethanol-induced liver cirrhosis. Am J Physiol 260: E338, 1991.
20. Schneeweiss B, Graninger W, Ferenci P, et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology 11: 387, 1990.
21. Heymstield SB, Waki M, Reinus J. Are patients with chronic liver disease hypermetabolic? Hepatology 11: 502, 1990.
22. Crawford DH, Shepherd RW, Halliday JW, et al. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology 106: 1611, 1994.
23. O'Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 2: 615, 1980.
24. Eriksson LS. Branched-chain amino acids in the treatment of hepatic encephalopathy. in: Hepatic Encephalopathy: Manage ment with Lactulose and Related Carbohydrates. Conn HO, Bircher J, Eds. Medi-Ed Press, East Lansing, 1988, p. 129.
25. O'Keefe SJD. Parenteral nutrition and liver disease, in: Clinical Nutrilion-Parenteral Nutrition. Rombeau JL, Caldwell MD, Eds. W.B. Saunders, Philadelphia, 1993, p. 676.
26. Campillo B, Bories PN, Pornin B, Devanley M. Influence of liver failure. ascites and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 13: 613, 1997.
27. Müller MJ, Böker KH, Selberg O. Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin Investig 72: 568, 1994.
28. Müller MJ, Lauts HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 15: 782, 1992.
29. Müller MJ, Loyal S, Schwarze M, et al. Resting energy expenditure and nutritional state in patients with liver cirrhosis before and 432 days after liver transplantation. Clin Nutr 13: 145, 1994.
30. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ. Identification of high- or low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25: 652, 1997.
31. 3D Müller MJ. Hepatic fuel selection. Proc Nutr Soc 54: 139, 1995.
32. Johnson DC, Alberti KG, Faber OK, Binder C. Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion. Lancet 1: 10, 1977.
33. Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14: 103, 1991.
34. Hayashida Y, Kido Y, Tsujinaka T, et al. Increased energy expenditure after intravenous administration of amino acids. JPEN J Parenteral Enterai Nutr 16: 142, 1992.
35. Munro HN, Fernstrom JD, Wurtman RJ. Insulin, plasma amino acid imbalance, and hepatic coma. Lancet 1: 722, 1975.
36. Ichihara A, Koyama E. Transaminase for branched chain amino acids. I. Branched chain amino acids-α-ketoglutarate transaminase. J Biochem (Tokyo) 59: 160, 1966.
37. Kalo M, Yoshida Y, Moriwaki H, Muto Y. Effect of branched-chain amino acid (BCAA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients. Acta Hepatol Jpn 25: 692, 1991 (in Japanese).
38. Usui T, Moriwaki H, Hatakeyama H, et al. Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J Nutr 126: 1412, 1996.
39. González J, Periago JL, Gil A, et al. Malnutrition-related polyunsaturated tatty acid changes in plasma lipid fractions of cirrhotic patients. Metabolism 41: 954, 1992.
40. Cabré E, Abad-Lacruz A, Núñez MC, et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am J Gastroenterol 88: 718, 1993.
41. Samson FE Jr, Dahl N, Dahl DR. A study on the narcotic action of the short chain fatty acids. J Clin Invest 35: 1291, 1956.
42. Muto Y, Takahashi Y, Kawamura H. Effect of short-chain fatty acids on the electrical activity of neo-, paleo-, and archicortical system. Brain Nerve 16: 601, 1964.
43. Muto Y. Clinical study on the relationship of short-chain fatty acids and hepatic encephalopathy. Jpn J Gastroenterol 63: 19, 1966.